Bridgebio Pharma (BBIO)Rep. Gilbert Cisneros (CA31) disclosed a partial sale $1K–$15K
Rep. Gilbert Cisneros (CA31) disclosed a partial sale of Bridgebio Pharma in the $1K–$15K range.
- $1,001–$15,000
- Reported range · official band, not an exact amount
- 13 days
- Disclosure lag
- Traded
- Sep 29, 2026
- Disclosed
- Oct 12, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Aug 10, 2026Company filing · Form 8-K · ResultsReported its results
- Aug 13, 2026Company filing · Form 8-K · Material agreement, Other newsSigned an important agreement, and reported other company news
- Sep 29, 2026 · this disclosureCongressDisclosed partial sale of BBIO — reported range $1,001 - $15,000
How to read House Clerk periodic transaction report
The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.
Full guide: What is the STOCK Act?
What else is on file for Bridgebio Pharma
For Bridgebio Pharma, OQRO holds 1 Congress trade report and 17 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BBIO page.
Other recent filings by Rep. Gilbert Cisneros (CA31)
- House Clerk periodic transaction report at Atricure (ATRC)Oct 12, 2026
- House Clerk periodic transaction report at Balchem Corporation (BCPC)Oct 12, 2026
- House Clerk periodic transaction report at Benchmark Electronics, Inc. (BHE)Oct 12, 2026
- House Clerk periodic transaction report at Broadcom (AVGO)Oct 12, 2026
- House Clerk periodic transaction report at Cincinnati Financial (CINF)Oct 12, 2026
The full history of Rep. Gilbert Cisneros (CA31) is on the profile page.
How this filing works
Other disclosures at Bridgebio Pharma
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
Everything OQRO holds on this company is on its BBIO page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data